Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COVID-19 convalescent plasma (Inova Health System)
- Development stage
- Unknown
- Lead developer
- Inova Health
- Administration
- Intravenous
01
Overview
Convalescent plasma-Inova Health Care Services-COVID-19 is a biological therapy developed by Inova Health Care Services for the treatment of severe or life-threatening COVID-19 in hospitalized patients. The therapy involves the transfusion of plasma collected from individuals who have recovered from SARS-CoV-2 infection, which contains high titers of virus-specific neutralizing antibodies. These antibodies provide passive immunity by binding to the SARS-CoV-2 spike protein, thereby preventing viral entry into host cells and suppressing viral replication. The efficacy and safety of this specific intervention were evaluated in the Phase 2/3 Inova-CCP clinical trial.
- Other names
- Convalescent plasmaCCPCOVID-19 convalescent plasmaCOVID19 convalescent plasmaCOVID 19 convalescent plasma
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on COVID-19 convalescent plasma (Inova Health System).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COVID-19 convalescent plasma (Inova Health System).